Related Experiment Video
Updated: Nov 9, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both
Dominique V M Verhaert1,2, Hans-Peter Brunner-La Rocca1, Dirk J van Veldhuisen3
1Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Insights
Atrial fibrillation (AF) and heart failure (HF) frequently coexist, worsening patient outcomes. This review explores their interconnectedness, management strategies, and future directions for treating these common cardiovascular conditions.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Atrial fibrillation (AF) and heart failure (HF) are highly prevalent cardiovascular diseases.
- These conditions often coexist, exacerbating each other and increasing mortality.
- Shared cardiovascular risk factors contribute to the independent and combined development of AF and HF.
Purpose of the Study:
- To review the pathophysiological links between AF and HF.
- To summarize current management strategies for patients with coexisting AF and HF.
- To discuss future perspectives in the treatment of these comorbidities.
Main Methods:
- Literature review of existing research on AF and HF pathophysiology and management.
- Analysis of the interplay between AF and HF as comorbidities.
- Discussion of clinical challenges and opportunities in managing combined AF and HF.
Main Results:
- AF and HF share common etiological factors and mutually influence disease progression.
- The management of coexisting AF and HF presents unique challenges requiring tailored therapeutic approaches.
- Optimal treatment strategies for these comorbidities are a subject of ongoing debate and research.
Conclusions:
- Understanding the pathophysiological coherence of AF and HF is crucial for effective clinical management.
- Integrated treatment strategies are necessary to address the complexities of coexisting AF and HF.
- Further research is needed to optimize therapeutic interventions and improve outcomes for patients with both conditions.
Abstract:
Atrial fibrillation (AF) and heart failure (HF) are both highly prevalent diseases and are accompanied by a significant disease burden and increased mortality. Although the conditions may exist independently, they often go hand in hand as each is able to provoke, sustain, and aggravate the other. In addition, the diseases share a risk profile with several coinciding cardiovascular risk factors, promoting the odds of developing both AF and HF separately from each other. When the diseases coexist, this provides additional challenges but also opportunities for the optimal treatment. The recommended management of the comorbidities has been much debated in the past decades. In this review, we describe the pathophysiological coherence of AF and HF, illustrate the current knowledge on the management of them as comorbidities of each other and look forward to future developments in this field.
More Related Videos
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Rheumatic Heart Disease III: Medical Management

